4‐{3‐[(Pyridin‐4‐ylmethyl)amino]‐[1,2,4]triazolo[4,3‐<i>b</i>][1,2,4]triazin‐6‐yl}phenol: An improved anticancer agent in hepatocellular carcinoma and a selective MDR1/MRP modulator

Zahra Zakeri Khatir(Mazandaran University of Medical Sciences), Hamid Irannejad(Mazandaran University of Medical Sciences)

Archiv der Pharmazie

March 5, 2024

10.1002/ardp.202300704

Cited by 1

Related Papers

Toward the Discovery of Novel Anti‐HIV Drugs. Second‐Generation Inhibitors of the Cellular ATPase DDX3 with Improved Anti‐HIV Activity: Synthesis, Structure–Activity Relationship Analysis, Cytotoxicity Studies, and Target Validation

|ChemMedChem|2011|105